Search - tctmd.com

Displaying 1 - 20 of 25

Sort: Relevancy | Date

News Daily News

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

Yael L. Maxwell

December 29, 2025

News Daily News

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

Todd Neale

June 06, 2025

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

Top Coronary Artery Disease News of 2023

Michael O'Riordan

December 22, 2023

News Conference News AHA 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

Michael O'Riordan

November 11, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Conference News TCT 2022

SCAAR Registry Delves Into Left Main Revascularization Outcomes

Michael O'Riordan

September 19, 2022

News Daily News

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Michael O'Riordan

December 09, 2021

News Daily News

Women Stand to Gain the Most From Standardized STEMI Protocols

Michael O'Riordan

September 30, 2021

News Daily News

Complete Revascularization Best for Most ACS Patients With MVD

Michael O'Riordan

June 25, 2021

News Daily News

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

Michael O'Riordan

September 16, 2020

News Conference News ESC 2020

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Caitlin E. Cox

September 03, 2020

News Daily News

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

Michael O'Riordan

August 07, 2020

News Daily News

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

Shelley Wood

December 20, 2019

News Daily News

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Michael O'Riordan

December 20, 2019

Taggart Rebuts EXCEL Response, Insisting on Retraction

News Daily News

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Michael O'Riordan

December 18, 2019

News Daily News

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Michael O'Riordan

July 03, 2019

News Daily News

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

L.A. McKeown

November 29, 2018

News Features

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

Michael O'Riordan

November 27, 2017

News Conference News AHA 2017

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Michael O'Riordan

November 15, 2017

Advertisement

Year in Review: DCBs Big in Coronary News, Along With Beta-blockers in STEMI

JACC Dedicates Issue to Deep Dive on Latest ACS Guidelines

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Top Coronary Artery Disease News of 2023

Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

SCAAR Registry Delves Into Left Main Revascularization Outcomes

New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT

Women Stand to Gain the Most From Standardized STEMI Protocols

Complete Revascularization Best for Most ACS Patients With MVD

‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk

New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials

Missing EXCEL MI Data Published, Prompting New Questions and Promised Answers

EACTS Calls for Independent Left Main CAD Evidence Review, Urges ESC Input

CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization

Taggart Rebuts EXCEL Response, Insisting Concerns Over MI and Mortality Remain

Field in Flux: What’s the Best Antithrombotic Strategy for A-fib Patients Undergoing PCI?

Women With Acute MI Less Likely to Survive or Receive Guideline-Recommended Care

Trajectory Unknown: How ORBITA Lands in Clinical Practice Still Up for Debate

‘De-escalating’ P2Y12 Inhibition Possible in Acute MI Patients: PRAGUE-18

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content